Literature DB >> 12672191

Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001.

Yannis Alamanos1, Paraskevi V Voulgari, Christos Siozos, Pelagia Katsimpri, Stylianos Tsintzos, Georgios Dimou, Eudokia N Politi, Antonia Rapti, Gianna Laina, Alexandros A Drosos.   

Abstract

OBJECTIVE: To investigate the frequency, distribution, and mortality of systemic lupus erythematosus (SLE) in a defined area of northwest Greece.
METHODS: Cases were recorded from 3 sources: inpatients and outpatients referred to the rheumatology clinic of the Ioannina University Hospital; inpatients and outpatients referred to the rheumatology clinic of Ioannina General Hospital; and patients referred to private rheumatologists practicing in the study area. All patients identified between January 1, 1982, and December 31, 2001, resident in the study area were included. Diagnosis was confirmed by the 1982 revised criteria of the American College of Rheumatology. Incidence and prevalence rates were calculated as number of cases per hundred thousand inhabitants. Population data were based on the 1981, 1991, and 2001 National Census.
RESULTS: A total of 178 cases of SLE were diagnosed during the study period, giving a mean annual incidence rate of 1.9 cases/100,000 inhabitants (95% CI 1.49-2.31). The female/male ratio was 7.4. A significant variation of SLE rates among different districts of the study area was observed. Incidence rates were higher for the urban population. The peak of incidence was observed in the 30-49 age group for both sexes. There was a slight increase in the incidence of SLE during the study period. The 5 year survival rate was 96.8% and the 10 year survival rate was 90.3%.
CONCLUSION: We found a relatively low frequency of SLE in northwest Greece. Age at diagnosis was younger than expected.

Entities:  

Mesh:

Year:  2003        PMID: 12672191

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Mortality in Systemic Lupus Erythematosus: an Updated Review.

Authors:  César E Fors Nieves; Peter M Izmirly
Journal:  Curr Rheumatol Rep       Date:  2016-04       Impact factor: 4.592

Review 2.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

3.  Prevalence and incidence of systemic lupus erythematosus in South Korea.

Authors:  Jee-Seon Shim; Yoon-Kyoung Sung; Young Bin Joo; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

4.  Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico.

Authors:  María J Molina; Angel M Mayor; Alejandro E Franco; Carlos A Morell; Miguel A López; Luis M Vilá
Journal:  J Clin Rheumatol       Date:  2007-08       Impact factor: 3.517

5.  The prevalence of rheumatic diseases in central Greece: a population survey.

Authors:  Ioannis Anagnostopoulos; Elias Zinzaras; Ioannis Alexiou; Aphrodite A Papathanasiou; Evangelos Davas; Athanasios Koutroumpas; Georgia Barouta; Lazaros I Sakkas
Journal:  BMC Musculoskelet Disord       Date:  2010-05-26       Impact factor: 2.362

Review 6.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

Review 7.  Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases.

Authors:  Glinda S Cooper; Milele L K Bynum; Emily C Somers
Journal:  J Autoimmun       Date:  2009-10-09       Impact factor: 7.094

Review 8.  Epidemiology of the rheumatic diseases of childhood.

Authors:  Prudence J Manners
Journal:  Curr Rheumatol Rep       Date:  2003-12       Impact factor: 4.592

9.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05

10.  Off-label use of rituximab for systemic lupus erythematosus in Europe.

Authors:  Monica Rydén-Aulin; Dimitrios Boumpas; Irene Bultink; Jose Luis Callejas Rubio; Luis Caminal-Montero; Antoni Castro; Agustín Colodro Ruiz; Andrea Doria; Thomas Dörner; Cristina Gonzalez-Echavarri; Elisa Gremese; Frederic A Houssiau; Tom Huizinga; Murat Inanç; David Isenberg; Annamaria Iuliano; Søren Jacobsen; Juan Jimenéz-Alonso; Lászlo Kovács; Xavier Mariette; Marta Mosca; Ola Nived; Joaquim Oristrell; Manuel Ramos-Casals; Javier Rascón; Guillermo Ruiz-Irastorza; Luis Sáez-Comet; Gonzalo Salvador Cervelló; Gian Domenico Sebastiani; Danilo Squatrito; Gabriella Szücs; Alexandre Voskuyl; Ronald van Vollenhoven
Journal:  Lupus Sci Med       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.